Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Total 13F shares
-
24,465,339
-
Share change
-
+803,787
-
Total reported value
-
$935,797,108
-
Price per share
-
$38.25
-
Number of holders
-
77
-
Value change
-
+$30,300,014
-
Number of buys
-
51
-
Number of sells
-
30
Institutional Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q2 2018
As of 30 Jun 2018,
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,465,339 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BOXER CAPITAL, LLC, JANUS HENDERSON GROUP PLC, BlackRock Inc., BB BIOTECH AG, FMR LLC, BRIDGER MANAGEMENT, LLC, and ArrowMark Colorado Holdings LLC.
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.